Regentis Biomaterials Ltd. (RGNT)
Regentis Biomaterials Market Cap: 36.36M for Dec. 29, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Compugen Ltd. | 138.43M |
| Pluri, Inc. | 27.39M |
| Can-Fite BioPharma Ltd. | 2.670M |
| BiomX, Inc. | 3.030M |
| Nasus Pharma Ltd. | 69.76M |
Market Cap Related Metrics
| Price | 7.02 |
| Earnings Yield | -16.35% |